Pharmalot By Ed Silverman Greece plans to go to court to seek compensation from Novartis over a bribery scandal
Pharmalot By Ed Silverman Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Color Code By Nicholas St. Fleur Listen: A ‘city on fire’: How Miami shaped a disputed diagnosis used to justify deaths in police custody
Biotech By Kate Sheridan When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
Pharmalot By Ed Silverman Former Glaxo scientists and the feds fight over reviewing allegedly stolen documents
Pharmalot By Ed Silverman European regulators issue final guidelines for redacting clinical trial data